Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Flap endonuclease 1 (FEN1) is a structure-specific nuclease encoded by the FEN1 gene, essential for DNA replication and repair in eukaryotic cells[1][2][3][4]. FEN1 removes 5' overhanging single-stranded DNA “flaps” generated during Okazaki fragment maturation in lagging strand synthesis and is essential in long-patch base excision repair[1][2][3]. It maintains genomic stability, interacting with other repair proteins (e.g., PCNA, APEX1, WRN) to coordinate DNA processing steps[1][2]. FEN1 is a key factor in cancer biology—its inhibition is selectively toxic to tumor cells with homologous recombination repair defects (notably, BRCA1/2-mutant tumors), making it a candidate therapeutic target in oncology[1]. FEN1's catalytic activity and substrate recognition are finely regulated by protein partners and post-translational modifications, and its dysfunction is associated with cancer, chromosomal instability, and disorders of premature aging[2][3][4].
Inhibition of FEN1 results in impaired DNA repair, promoting synthetic lethality in tumor cells deficient in homologous recombination repair pathways (such as those with BRCA1/2 mutations)[1]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flap endonuclease 1 (FEN1).